<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Dev Immunol</journal-id><journal-id journal-id-type="publisher-id">CDI</journal-id><journal-title>Clinical and Developmental Immunology</journal-title><issn pub-type="ppub">1740-2522</issn><issn pub-type="epub">1740-2530</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1155/2009/374696</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Does <italic>Toxoplasma gondii</italic> Infection Affect the Levels of IgE and Cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Matowicka-Karna</surname><given-names>Joanna</given-names></name><xref ref-type="aff" rid="I1"/><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Dymicka-Piekarska</surname><given-names>Violetta</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Kemona</surname><given-names>Halina</given-names></name><xref ref-type="aff" rid="I1"/></contrib></contrib-group><aff id="I1">Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, J. Waszyngton'a 15A, 15-269 Bialystok, Poland</aff><author-notes><corresp id="cor1">*Joanna Matowicka-Karna: <email>matowic@umwb.edu.pl</email></corresp><fn fn-type="other"><p>Recommended by Bernhard Fleischer</p></fn></author-notes><pub-date pub-type="ppub"><year>2009</year></pub-date><pub-date pub-type="epub"><day>25</day><month>5</month><year>2009</year></pub-date><volume>2009</volume><elocation-id>374696</elocation-id><history><date date-type="received"><day>23</day><month>12</month><year>2008</year></date><date date-type="accepted"><day>18</day><month>3</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Joanna Matowicka-Karna et al.</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>In the study performed in a group of patients infected with <italic>T. gondii</italic>, we evaluated Th2 humoral response (IL-5, IL-6, IL-10) and Th1 cell response (IL-12, TNF-<italic>&#x003b1;</italic>). The study objective was to assess the effect of <italic>T. gondii</italic> on chosen indices of the immune response. The study involved 52 women infected with <italic>T. gondii</italic> (aged 18&#x02013;42 years) prior to antiparasitic treatment. In all the patients, we found IgM (index &#x0003e;0.7) and IgG which exceeded 300 IU/ml. The control group (C) consisted of 40 healthy women aged 18&#x02013;46 years. In the study group (T) and in the control group (C), the levels of IgE, IL-5, IL-6, IL-10, IL-12, and TNF-<italic>&#x003b1;</italic> were determined. In our study, <italic>T. gondii</italic> patients had twofold higher levels of IL-5 and IL-6 as compared to healthy subjects, which seems to confirm the presence of an inflammatory state. We found the level of IL-10 to be fivefold higher in the course of <italic>toxoplasmosis</italic> than in healthy controls. The levels of IL-12 and TNF-<italic>&#x003b1;</italic> were comparable to those observed in healthy controls. The study has revealed that patients infected with <italic>T. gondii</italic> show increased production of the humoral response cytokines, whereas the generation of the cell response cytokines remains unchanged.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. Introduction</title><p><italic> Toxoplasma gondii</italic> is a ruthless intracellular parasite belonging to <italic>Coccidae</italic>. <italic>T. gondii</italic> occurs in three forms: tachyzoites, bradyzoites (in tissues), and sporozoites. The parasite locates in the brain, heart, lungs, and most frequently in the lymph nodes. <italic>Toxoplasmosis</italic> is a disease affecting 500 million people worldwide. The seroprevalence varies (from 5% to 90%), depending on geographical location, age, habit of eating raw meat or unwashed fruit and vegetables, and general level of hygiene. The incidence of infections is higher in warmer and humid climate and increases with age. The disease can be congenital or acquired [<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B4">4</xref>]. The parasite after invading the human body multiplies inside the cell, causing damage to the reticuloendothelial system. Rapid multiplication of the parasite and formation of the so-called pseudocysts are characteristics of the acute phase of invasion [<xref ref-type="bibr" rid="B5">5</xref>]. </p><p>In parasitic invasions, an increase is observed in the production of IgE antibodies, especially in helminth infections. This defect results from disturbances in the regulation of antibody production by Th cells, which promotes local inflammatory reaction. Via release of mediators from mast cells IgE participates in the reaction of antibody-dependent cellular cytotoxicity (ADCC). Cytotoxic activity of eosinophils is increased under the influence of cytokines (TNF-<italic>&#x003b1;</italic> and IL-5) released by mast cells, lymphocytes, and macrophages [<xref ref-type="bibr" rid="B6">6</xref>]. Th2 lymphocytes synthesize specific cytokines (IL-4, IL-5, IL-6, IL-10, IL-13, and IL-14), which play a major role in the pathogenesis of parasitic diseases. IL-5 is the major cytokine responsible for the increase in the eosinophil population in parasitoses, whereas IL-6 stimulates production of antibodies and exerts a proinflammatory effect by stimulating the generation of acute phase proteins. IL-10 and IL-12 control the type of the immune response. The former inhibits cytokine synthesis and by blocking the production of IL-6 and TNF-<italic>&#x003b1;</italic> causes an advantage of the response occurring with Th2 involvement and B cell activation. However, IL-12 facilitates formation of a Th1 type response [<xref ref-type="bibr" rid="B7">7</xref>&#x02013;<xref ref-type="bibr" rid="B10">10</xref>].</p><p>In the current study, performed on a group of patients infected with <italic>T. gondii, </italic>we evaluated humoral response (IL-5, IL-6, IL-10 secreted by Th2 cells) and cell response (IL-12 and TNF-<italic>&#x003b1;</italic> secreted by Th1 cells). The study objective was to assess the effect of <italic>T. gondii</italic> on chosen indices of the immune response. </p></sec><sec sec-type="section" id="sec2"><title>2. Materials and Methods</title><p>The study involved 52 women infected with <italic>T. gondii</italic> (aged 18&#x02013;42 years) prior to antiparasitic treatment. All these women had swollen cervical and nuchal lymph nodes (toxoplasmic lymphadenopathy), although other diseases were excluded (mononucleosis, cytomegaly, granulomatosis, lymphomas, leukemias, AIDS). Tests were performed in the women who were not able to conceive. In all the patients (group T), the levels of specific IgM and IgG antibodies, directed against <italic>T. gondii,</italic> were determined. In all the women, IgM was present (index &#x0003e; 0.7) and the level of IgG exceeded 300 IU/ml. The diagnosis of the early phase of <italic>T. gondii</italic> infection was based on the detection of a significant increase in the levels of specific IgG antibodies of low avidity, with the co-occurrence of IgM antibodies. Assays were performed using ELFA on an immunoserological analyzer VIDAS with a set of reagents (bioMerieux). The control group (C) consisted of 40 healthy women aged 18&#x02013;46 years, clinically asymptomatic, who underwent prophylactic examinations and had no anti-<italic>T. gondii</italic> specific antibodies.</p><p>The levels of IgE, IL-5, IL-6, IL-10, IL-12, and TNF-<italic>&#x003b1;</italic> were determined in the study group (T) and in the control group (C). </p><sec id="sec2.1"><title>2.1. Determination of Total IgE</title><p>Total IgE level was determined in 100 <italic>&#x003bc;</italic>l serum samples by ELFA (bioMerieux, France) on an immunoserological analyzer VIDAS. The sensitivity threshold of the method is 0.5 KIU/l. </p></sec><sec id="sec2.2"><title>2.2. Determination of the Levels of Interleukins (IL-5, IL-6, IL- 10, IL-12) and TNF-<italic>&#x003b1;</italic></title><p>The levels of interleukins and TNF-<italic>&#x003b1;</italic> were determined in blood serum using ELISA method with a set of Quantikine human (R&#x00026;D, USA). </p><p>The results were subjected to statistical analysis using the program Statistica 8.0. The differences were considered statistically significant when the value of test function was at the level of significance set at <italic>P</italic> &#x0003c; .05. The Kolgomorov consistency test was used for features consistent with normal distribution, the <italic>t</italic>-Student test for comparisons between the groups and the Mann-Whitney test for traits inconsistent with this distribution. </p></sec></sec><sec sec-type="section" id="sec3"><title>3. Results</title><p> In patients infected with <italic>T. gondii</italic> the mean IgE level was 74.7 &#x000b1; 105.5 IU/l, being twice as high as the mean IgE value in healthy individuals (37.7 &#x000b1; 27.6 IU/l). The difference between these values is statistically significant (<italic>P</italic> &#x0003c; .05).</p><p>The mean level of IL-5 in <italic>T. gondii</italic> infection was 7.02 &#x000b1; 2.9 pg/ml. However, in healthy subjects, the IL-5 concentration was markedly lower (mean 3.5 &#x000b1; 1.6 pg/ml). The difference between these values is statistically significant (<italic>P</italic> &#x0003c; .0001). </p><p>The mean level of IL-6 in <italic>T. gondii-</italic>infected patients was 5.21 &#x000b1; 3.5 pg/ml, being twice as high as the mean value in healthy controls (2.45 &#x000b1; 1.4 pg/ml). The difference in the values of IL-6 between the infected and healthy subjects is statistically significant (<italic>P</italic> &#x0003c; .0001). </p><p>The level of IL-10 was found to be most highly differentiated. In the course of <italic>toxoplasmosis</italic> its mean level was 4.50 &#x000b1; 2.9 pg/ml whereas in healthy controls only 0.76 &#x000b1; 0.2 pg/ml. The difference between these values is highly statistically significant (<italic>P</italic> &#x0003c; .0001). However, a comparison of the mean levels of IL-12 and TNF-<italic>&#x003b1;</italic> between <italic>T. gondii</italic> patients and healthy subjects did not reveal any statistically significant differences (0.4 &#x0003c; <italic>P</italic> &#x0003c; .5).</p></sec><sec sec-type="section" id="sec4"><title>4. Discussion</title><p> The prevalence of <italic>T. gondii</italic> has been reported to increase with age (&#x0003e;40 years) and in women consuming raw meat, vegetables, and fruit [<xref ref-type="bibr" rid="B11">11</xref>]. In the acute phase, directly after invading the body, <italic>T. gondii</italic> begins to multiply rapidly. In a majority of cases, acquired <italic>toxoplasmosis</italic> is asymptomatic. In the second week of infection, specific IgM antibodies are present in the blood. IgE antibodies also appear at the same time, slightly preceding specific IgA antibodies, but they are not found 4 months after the infection onset [<xref ref-type="bibr" rid="B12">12</xref>]. In our study, the concentration of IgE antibodies in patients infected with <italic>T. gondii</italic> was statistically significantly higher than in healthy subjects, which was accompanied by an elevated level of IgM antibodies, thus suggesting an acute form of invasion. Increased IgE level correlates with early acute inflammation or with a reactive form of <italic>toxoplasmosis</italic>. However, negative IgE test result does not exclude acute <italic>toxoplasmosis</italic> [<xref ref-type="bibr" rid="B13">13</xref>]. Dziubek et al. [<xref ref-type="bibr" rid="B14">14</xref>] who determined specific antibodies directed against <italic>T. gondii</italic> (IgM, IgG, IgA) and CD4+ and CD8+ lymphocyte subpopulations found more substantial involvement of CD8+, whereas lower expression of CD4+ lymphocytes might be due to a suppressive action of the parasite.</p><p>The humoral response involves IL-5 and IL-6 that exert a proinflammatory effect and IL-10 inhibiting the action of IL-6. Patients infected with <italic>T. gondii</italic> had twofold higher values of IL-5 as compared to healthy subjects. IL-5 prolongs eosinophil survival, stimulates eosinophil degranulation and production of reactive oxygen species, and exerts a chemotactic effect on these cells [<xref ref-type="bibr" rid="B15">15</xref>]. It has been proved that <italic>Toxocara canis</italic> invasion promotes release of IL-5, IL-8, and TNF-<italic>&#x003b1;</italic>, which is accompanied by eosinophilia with an inflammatory state [<xref ref-type="bibr" rid="B16">16</xref>]. However, Nickdel et al. [<xref ref-type="bibr" rid="B17">17</xref>] have shown that at the early stage of <italic>T. gondii</italic> infection, coexisting with eosinophilia and increased level of IL-5, pathological changes are prominent in the small intestine, which is accompanied by a simultaneous reduction in IL-12 and IFN-<italic>&#x003b3;</italic>. We also noted an increase in the level of IL-5 and a decrease in the level of IL-12. However, Filisetti and Candolfi [<xref ref-type="bibr" rid="B18">18</xref>] revealed an IL-5 induced increase in IL-12 production in <italic>toxoplasmosis</italic>. A decrease in the production of IL-12 and inhibition of Th1 response have been reported by Lang et al. [<xref ref-type="bibr" rid="B7">7</xref>].</p><p>In our study, <italic>T. gondii</italic> patients had a twofold higher level of IL-6 as compared to healthy subjects, which seems to confirm the presence of an inflammatory state. The major function of IL-6 is the involvement in the immune response through the action on lymphocytes B. It is a mediator responsible for the production of acute phase proteins and increased cytotoxic activity of NK cells. IL-6 is an early and sensitive, although nonspecific, marker of inflammatory states.</p><p>We found the level of IL-10 to be fivefold higher in the course of <italic>toxoplasmosis</italic> than in healthy controls. Therefore, we could have expected a decrease in IL-6 production, which was however not found. IL-10 plays an essential role in the inflammatory response during acute <italic>T. gondii</italic> infection, since it inhibits the cellular-type immune response (IL-12, TNF-<italic>&#x003b1;</italic>) and inflammatory response (IL-6) [<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B19">19</xref>]. IL-10 counteracts the harmful effects of the inflammatory response which is based on the increased production of TNF-<italic>&#x003b1;</italic>, IFN-<italic>&#x003b3;</italic>, and NO associated with intestinal multiplication of <italic>T. gondii</italic> [<xref ref-type="bibr" rid="B20">20</xref>]. IL-10 is able to deactivate macrophages, induce IFN-<italic>&#x003b3;</italic> by <italic>T. gondii</italic>, and facilitate intracellular parasite survival. IL-10 induces immunosuppression during <italic>T. gondii</italic> invasion, which is beneficial both for the host and the parasite [<xref ref-type="bibr" rid="B7">7</xref>].</p><p>Also the cellular response, involved among others IL-12 and TNF-<italic>&#x003b1;</italic>, plays an important role in parasitic invasions. In our patients infected with <italic>T. gondii</italic>, the levels of IL-12 and TNF-<italic>&#x003b1;</italic> were comparable to those observed in healthy controls. IL-12 was found to increase the production of IgG but not to inhibit IgE. IFN-<italic>&#x003b3;</italic>, IL-2, and IL-12 are involved in the protection against parasitic invasions. IL-12 stimulates the production of IFN-<italic>&#x003b3;</italic> and TNF-<italic>&#x003b1;</italic> and activates lymphocyte cytotoxicity [<xref ref-type="bibr" rid="B1">1</xref>]. Involvement of IFN-<italic>&#x003b3;</italic> and IL-10 in the immune mechanisms directed against <italic>T. gondii</italic> has been described by Kang et al. [<xref ref-type="bibr" rid="B21">21</xref>]. According to Filisetti and Candolfi [<xref ref-type="bibr" rid="B18">18</xref>], secretion of IFN-<italic>&#x003b3;</italic> in mice increases the phagocytic activity of macrophages and cytotoxic activity of CD8+T lymphocytes. Increased production of IFN-<italic>&#x003b3;</italic> is strongly correlated with parasite virulence and enhanced apoptosis.</p><p>In our study, in the course of <italic>toxoplasmosis</italic> the levels of TNF-<italic>&#x003b1;</italic> and IL-12 did not change, whereas the concentration of IL-5 increased. However, as reported by Lang et al. (2007) <italic>T. gondii</italic> inhibits production of TNF-<italic>&#x003b1;</italic> and IL-12. TNF-<italic>&#x003b1;</italic> is a cytokine of inflammatory and immune response and together with IL-6 can enhance proliferation and differentiation of B lymphocytes [<xref ref-type="bibr" rid="B7">7</xref>]. TNF-<italic>&#x003b1;</italic> activates eosinophil cytotoxicity toward protozoa and induces secretion of acute phase proteins via IL-6 production. TNF-<italic>&#x003b1;</italic> and IFN-<italic>&#x003b3;</italic> have antiproliferative properties. In <italic>toxoplasmosis,</italic> TNF-<italic>&#x003b1;</italic> appears to be indispensable for macrophage activation and inhibition of parasite replication; however, this is possible only in cooperation with IFN-<italic>&#x003b3;</italic>. </p><p>The study has revealed that patients infected with <italic>T. gondii</italic> show increased production of the cytokines responsible for humoral response, whereas generation of the cell response cytokines remains unchanged. </p></sec></body><back><ref-list><ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evering</surname><given-names>T</given-names></name><name><surname>Weiss</surname><given-names>LM</given-names></name></person-group><article-title>The immunology of parasite infections in immunocompromised hosts</article-title><source><italic>Parasite Immunology</italic></source><year>2006</year><volume>28</volume><issue>11</issue><fpage>549</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">17042927</pub-id></citation></ref><ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hegab</surname><given-names>SM</given-names></name><name><surname>Al-Mutawa</surname><given-names>SA</given-names></name></person-group><article-title>Immunopathogenesis of <italic>toxoplasmosis</italic></article-title><source><italic>Clinical and Experimental Medicine</italic></source><year>2003</year><volume>3</volume><issue>2</issue><fpage>84</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">14598184</pub-id></citation></ref><ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lappalainen</surname><given-names>M</given-names></name><name><surname>Hedman</surname><given-names>K</given-names></name></person-group><article-title>Serodiagnosis of <italic>toxoplasmosis</italic>. The impact of measurement of IgG avidity</article-title><source><italic>Annali dell'Istituto Superiore di Sanita</italic></source><year>2004</year><volume>40</volume><issue>1</issue><fpage>81</fpage><lpage>88</lpage></citation></ref><ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>LA</given-names></name><name><surname>Rocha</surname><given-names>RJ</given-names></name><name><surname>Rossi</surname><given-names>CL</given-names></name></person-group><article-title>Evaluation of serological markers for the immunodiagnosis of acute acquired <italic>toxoplasmosis</italic></article-title><source><italic>Journal of Medical Microbiology</italic></source><year>2001</year><volume>50</volume><issue>1</issue><fpage>62</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">11192507</pub-id></citation></ref><ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biesiada</surname><given-names>G</given-names></name><name><surname>Kalinowska-Nowak</surname><given-names>A</given-names></name><name><surname>Czepiel</surname><given-names>J</given-names></name><name><surname>Mach</surname><given-names>T</given-names></name></person-group><article-title><italic>Toxoplasmosis</italic>&#x02014;epidemiology, clinical manifestation and infection in pregnant women</article-title><source><italic>Przegl&#x00105;d Lekarski</italic></source><year>2006</year><volume>63</volume><issue>2</issue><fpage>97</fpage><lpage>99</lpage></citation></ref><ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nickdel</surname><given-names>MB</given-names></name><name><surname>Roberts</surname><given-names>F</given-names></name><name><surname>Brombacher</surname><given-names>F</given-names></name><name><surname>Alexander</surname><given-names>J</given-names></name><name><surname>Roberts</surname><given-names>CW</given-names></name></person-group><article-title>Counter-protective role for interleukin-5 during acute <italic>Toxoplasma gondii</italic> infection</article-title><source><italic>Infection and Immunity</italic></source><year>2001</year><volume>69</volume><issue>2</issue><fpage>1044</fpage><lpage>1052</lpage><pub-id pub-id-type="pmid">11160001</pub-id></citation></ref><ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>C</given-names></name><name><surname>Gro&#x000df;</surname><given-names>U</given-names></name><name><surname>L&#x000fc;der</surname><given-names>CGK</given-names></name></person-group><article-title>Subversion of innate and adaptive immune responses by <italic>Toxoplasma gondii</italic></article-title><source><italic>Parasitology Research</italic></source><year>2007</year><volume>100</volume><issue>2</issue><fpage>191</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">17024357</pub-id></citation></ref><ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Romagnani</surname><given-names>S</given-names></name></person-group><article-title>Understanding the role of Th1/Th2 cells in infection</article-title><source><italic>Trends in Microbiology</italic></source><year>1996</year><volume>4</volume><issue>12</issue><fpage>470</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">9004401</pub-id></citation></ref><ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vilcek</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>TH</given-names></name></person-group><article-title>Tumor necrosis factor: new insights into the molecular mechanisms of its multiple actions</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>1991</year><volume>266</volume><issue>12</issue><fpage>7313</fpage><lpage>7316</lpage><pub-id pub-id-type="pmid">1850405</pub-id></citation></ref><ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zaccone</surname><given-names>P</given-names></name><name><surname>Fehervari</surname><given-names>Z</given-names></name><name><surname>Phillips</surname><given-names>JM</given-names></name><name><surname>Dunne</surname><given-names>DW</given-names></name><name><surname>Cooke</surname><given-names>A</given-names></name></person-group><article-title>Parasitic worms and inflammatory diseases</article-title><source><italic>Parasite Immunology</italic></source><year>2006</year><volume>28</volume><issue>10</issue><fpage>515</fpage><lpage>523</lpage><pub-id pub-id-type="pmid">16965287</pub-id></citation></ref><ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Studeni&#x0010d;ov&#x000e1;</surname><given-names>C</given-names></name><name><surname>Ben&#x0010d;aiov&#x000e1;</surname><given-names>G</given-names></name><name><surname>Holkov&#x000e1;</surname><given-names>R</given-names></name></person-group><article-title>Seroprevalence of <italic>Toxoplasma gondii</italic> antibodies in a healthy population from Slovakia</article-title><source><italic>European Journal of Internal Medicine</italic></source><year>2006</year><volume>17</volume><issue>7</issue><fpage>470</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">17098589</pub-id></citation></ref><ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>M</given-names></name></person-group><article-title>Use of the ISAGA method in detection of specific IgM, IgA, IgE antibodies in acquired and congenital toxoplasmosis</article-title><source><italic>Wiadomo&#x0015b;ci Parazytologiczne</italic></source><year>1997</year><volume>43</volume><issue>1</issue><fpage>39</fpage><lpage>51</lpage></citation></ref><ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>U</given-names></name><name><surname>Keksel</surname><given-names>O</given-names></name><name><surname>Dard&#x000e9;</surname><given-names>ML</given-names></name></person-group><article-title>Value of detecting immunoglobulin E antibodies for the serological diagnosis of <italic>Toxoplasma gondii</italic> infection</article-title><source><italic>Clinical and Diagnostic Laboratory Immunology</italic></source><year>1997</year><volume>4</volume><issue>3</issue><fpage>247</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">9144357</pub-id></citation></ref><ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dziubek</surname><given-names>Z</given-names></name><name><surname>Zarnowska</surname><given-names>H</given-names></name><name><surname>Basiak</surname><given-names>W</given-names></name><name><surname>G&#x000f3;rski</surname><given-names>A</given-names></name><name><surname>Kajfasz</surname><given-names>P</given-names></name></person-group><article-title>Some aspects of immune response in <italic>toxoplasmosis</italic></article-title><source><italic>Przeglad Epidemiologiczny</italic></source><year>2001</year><volume>55</volume><issue>4</issue><fpage>495</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">11921737</pub-id></citation></ref><ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faccioli</surname><given-names>LH</given-names></name><name><surname>Vargaftig</surname><given-names>BB</given-names></name><name><surname>Medeiros</surname><given-names>AI</given-names></name><name><surname>Malheiros</surname><given-names>A</given-names></name></person-group><article-title>Cytokines in the modulation of eosinophilia</article-title><source><italic>Mem&#x000f3;rias do Instituto Oswaldo Cruz</italic></source><year>1997</year><volume>92</volume><issue>supplement 2</issue><fpage>109</fpage><lpage>114</lpage></citation></ref><ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faccioli</surname><given-names>LH</given-names></name><name><surname>Medeiros</surname><given-names>AI</given-names></name><name><surname>Malheiro</surname><given-names>A</given-names></name><name><surname>Pietro</surname><given-names>RCLR</given-names></name><name><surname>Januario</surname><given-names>A</given-names></name><name><surname>Vargaftig</surname><given-names>BB</given-names></name></person-group><article-title>Interleukin-5 modulates interleukin-8 secretion in eosinophilic inflammation</article-title><source><italic>Mediators of Inflammation</italic></source><year>1998</year><volume>7</volume><issue>1</issue><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">9839698</pub-id></citation></ref><ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nickdel</surname><given-names>MB</given-names></name><name><surname>Lyons</surname><given-names>RE</given-names></name><name><surname>Roberts</surname><given-names>F</given-names></name><etal/></person-group><article-title>Intestinal pathology during acute <italic>toxoplasmosis</italic> is IL-4 dependent and unrelated to parasite burden</article-title><source><italic>Parasite Immunology</italic></source><year>2004</year><volume>26</volume><issue>2</issue><fpage>75</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">15225294</pub-id></citation></ref><ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Filisetti</surname><given-names>D</given-names></name><name><surname>Candolfi</surname><given-names>E</given-names></name></person-group><article-title>Immune response to <italic>Toxoplasma gondii</italic></article-title><source><italic>Annali dell'Istituto Superiore di Sanita</italic></source><year>2004</year><volume>40</volume><issue>1</issue><fpage>71</fpage><lpage>80</lpage></citation></ref><ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>EH</given-names></name><name><surname>Wille-Reece</surname><given-names>U</given-names></name><name><surname>Dzierszinski</surname><given-names>F</given-names></name><name><surname>Hunter</surname><given-names>CA</given-names></name></person-group><article-title>A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis</article-title><source><italic>Journal of Neuroimmunology</italic></source><year>2005</year><volume>165</volume><issue>1-2</issue><fpage>63</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">16005735</pub-id></citation></ref><ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liesenfeld</surname><given-names>O</given-names></name></person-group><article-title>Immune responses to <italic>Toxoplasma gondii</italic> in the gut</article-title><source><italic>Immunobiology</italic></source><year>1999</year><volume>201</volume><issue>2</issue><fpage>229</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">10631572</pub-id></citation></ref><ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>K-N</given-names></name><name><surname>Choi</surname><given-names>I-U</given-names></name><name><surname>Shin</surname><given-names>D-W</given-names></name><name><surname>Lee</surname><given-names>Y-H</given-names></name></person-group><article-title>Cytokine and antibody responses of reactivated murine <italic>toxoplasmosis</italic> upon administration of dexamathasone</article-title><source><italic>The Korean Journal of Parasitology</italic></source><year>2006</year><volume>44</volume><issue>3</issue><fpage>209</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">16969058</pub-id></citation></ref></ref-list></back></article> 